This is a running list of biopharma startups that have raised significant venture funding in 2018. I update this manually from press releases so will there will likely be a lag in updating this, and I'll certainly miss some. If I missed anything let me know!

This list can hopefully be useful in a few ways:

• Stay up to date on venture financing trends
• Get a sense of which investors are the most active
• Get a sense for the types of deals investors are funding
• Create a shortlist of companies that may be hiring. Companies that raise large rounds generally will hire actively, and a large recent fundraise from good investors usually indicates the company is high quality and would be a good place for a young scientist to work

By way of commentary, I'll just add that 2018 is on pace to be the best year ever for biopharma startup funding. As of April 26, investors have invested over $5B in biopharma startups. For reference, biopharma startups raised over $10B in 2017, VR/AR startups raised $1.9B in 2016, and AI startups raised $5B in 2016. Almost $2B of this has been Series A investments (a company's first venture round, although these days companies are raising seven-figure "seed" rounds before a Series A) with an average / median deal size of $54M / $39M.